| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |